BriaCell has successfully completed its Phase I safety and tolerability evaluation of Bria-IMT™ in combination ...
PHILADELPHIA and VANCOUVER, British Columbia, Oct. 12, 2022 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: ...
Accessibility Tools